Navigation Links
Halozyme Therapeutics to Host Research Day for Investors and Analysts
Date:10/1/2008

SAN DIEGO, Oct. 1 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that it will host a Research Day on Wednesday, October 8, beginning at 12:15 p.m. EDT. A webcast of the presentations will be available live on the company website.

PRESENTATIONS

-- Strategic Company Overview, Jonathan Lim, M.D., President and Chief Executive Officer

-- Science and Technology Overview, Gregory Frost, Ph.D., Vice President and Chief Scientific Officer

-- Insulins -- Faster Acting, Regular and Analog, Douglas B. Muchmore, M.D., Vice President, Endocrinology Clinical Development

-- Bisphosphonates -- Advantages of Subcutaneous Injection with rHuPH20, Douglas B. Muchmore, M.D., Vice President, Endocrinology Clinical Development

-- PEGPH20 -- A Targeted Therapy for Cancer Treatment, Patrick O'Connor, Ph.D., Vice President, Research

-- Chemophase -- Next Steps to Pivotal Trials, Richard C. Yocum, M.D., Vice President, Clinical Development and Medical Affairs

-- Commercial Opportunities -- The Value Proposition, Robert L. Little, Vice President and Chief Commercial Officer

Halozyme will conduct a live webcast of the presentations beginning at 12:15 p.m. EDT. To access the webcast over the internet, please go to the company website at http://www.halozyme.com. An archive of the presentation will be available on Halozyme's website shortly after the conclusion of the meeting.

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the drug delivery, metabolism, oncology, and dermatology markets. The company's portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cumulase(R), for use in in-vitro fertilization, and HYLENEX, for use as an adjuvant to increase the absorption and dispersion of other injected drugs and fluids. HYLENEX is partnered with Baxter International Inc. Halozyme also has a number of different enzymes in its portfolio that target significant areas of unmet medical need. For more information visit http://www.halozyme.com.

Halozyme Contact Media Contacts

Robert H. Uhl Karen Sparks / Joleen Schultz

Senior Director, Mentus

Investor Relations (858) 455-5500, x275/x215

(858) 704-8264 karen@mentus.com

ruhl@halozyme.com jschultz@mentus.com


'/>"/>
SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
2. Halozyme Therapeutics to Present at Upcoming Investor Conferences
3. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
4. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
5. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
6. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
7. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
8. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
9. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
10. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
11. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... December 9, 2016 The research ... five players in the  Global Label-Free Array Systems Market ... market in 2015. Players such as Biacore, Agilent Technologies, ... dominant in the global market due to their unmatched ... innovation. Product upgrades and timely product launches are expected ...
(Date:12/8/2016)... 2016  The Board of Directors of the ... Pennsylvania,s only pure life sciences investment firm, ... the succession plan developed by the Nominating and Governance ... James (Jim) F. Jordan is selected to serve ... W. Manzetti , who is elected to the position ...
(Date:12/8/2016)... India , December 8, 2016 ... a comprehensive analysis, titled Global Amyloglucosidase Industry 2016 Market Research ... classification, application, and industry chain overview are all covered in ... SWOT analysis, and investment return analysis of the Amyloglucosidase industry. ... , , ...
(Date:12/8/2016)... ... 2016 , ... Opal Kelly, a leading producer of powerful ... or PCI Express, announced the FOMD-ACV-A4, the company's first FPGA-on-Module for integration applications ... module that fits a standard 204-pin SODIMM socket for low-cost integrations and includes ...
Breaking Biology Technology:
(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
(Date:11/21/2016)...   Neurotechnology , a provider of high-precision ... that the MegaMatcher On Card fingerprint matching algorithm ... NIST Minutiae Interoperability Exchange (MINEX) III ... of the evaluation protocol. The ... fingerprint templates used to establish compliance of template ...
(Date:11/16/2016)... SANTA CLARA, Calif. , Nov. 16, 2016 /PRNewswire/ ... company enhancing user experience and security for consumer ... provider for the financial and retail industry, today ... more secure and convenient way to authenticate users ... now uses Sensory,s TrulySecure™ software which ...
Breaking Biology News(10 mins):